News Detail
New Delhi, 25 Feb 2025: The Central Drugs Standard Control Organization (CDSCO) has announced the renaming of its existing PSUR/PV/AEFI Division to the Post Marketing Drugs Safety Monitoring Division (PMDSM), effective immediately. This office View Details
Source : DrugsControl Media Services
CDSCO
DCGI
renaming
PSUR/PV/AEFI Division
Post Marketing Drugs Safety Monitoring Division (PMDSM)
Related News
- Ensure no prescription drugs sold illegally, HC directs CBI, NCB (25-02-2025)
- Drugs & Cosmetics Act: Only Sessions Court Can Try Offences Punishable Under Chapter IV (25-02-2025)
- SC calls for mechanism under law for misleading ads complaints (25-02-2025)
- Maharashtra Medical Council Launches ‘Know Your Doctor’ Platform to Curb quackery (25-02-2025)
- 3 in 5 individuals in India die after cancer diagnosis: Study (25-02-2025)
- International Vaccine Institute launches new biorepository in South Korea (25-02-2025)
- MoU signed for inter-ministerial cooperation for promotion of 'One Herb, One Standard' (25-02-2025)
- 9 more firms had permission to produce now banned drug: Maha FDA (25-02-2025)
- SC Seeks State Responses on ARV Drug Quality Concerns (25-02-2025)
- CDSCO Issues Final Call for Pre-1988 FDC Manufacturers to Submit Applications (25-02-2025)